New epidemiologic and biologic knowledge of the natural history genital human papillomavirus (HPV) infections is rapidly being accumulated. There is overwhelming evidence that most HPV infections are transient particularly in the adolescent, and are not clinically important. There is a small proportion of adult women however, who harbour persistent HPV infections. These women are at considerable risk of developing high grade intra-epithelial neoplasia, and, if undetected and untreated invasive carcinoma.Screening, diagnostic, and management strategies should be tailored according to the HPV-related carcinoma risk potential of a specific area in the lower genital tract. The cervix is undoubtedly the site which carries the highest carcinoma risk among the areas along the lower genital tract. Molecular technology is now available or detecting and typing efficiently HPV DNA. This HPV testing has been shown to be useful in guiding management of women with minor grade cytologic atypia. The HPV DNA triage approach considerably reduces unnecessary colposcopies and the cost of managing this category o women.Several alternatives are available for treating patients with genital HPV infections. The most attractive advances made in the treatment of infra-epithelial cervical lesions and external genital warts are the loop electrosurgical excision procedure and the topical application of an immuno-enhancer agent respectively. The ultimate goal for the prevention and treatment of HPV infections is centred on the development of HPV vaccines.
Read full abstract